Quantcast

Latest Amines Stories

2014-03-04 08:23:55

DUBLIN, Mar. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cllvs5/glyphosate_market ) has announced the addition of the "Concise Analysis of the International Glyphosate Market for Genetically Modified and Conventional Crops - Forecasts to 2019" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) The global glyphosate market is expected to be driven by rising adoption of glyphosate tolerant GM crops and increasing...

2014-02-28 12:23:40

DUBLIN, February 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/ln78vx/tertbutylamine) has announced the addition of the "Tert-Butylamine (CAS 75-64-9) Market Research Report" [http://www.researchandmarkets.com/research/ln78vx/tertbutylamine ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Tert-Butylamine (CAS 75-64-9) Market Research Report presents comprehensive data on...

2014-02-20 12:30:20

DUBLIN, February 20, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/gpfnlw/glyphsoate_china) has announced the addition of the "Glyphsoate China Monthly Report" [http://www.researchandmarkets.com/research/gpfnlw/glyphsoate_china ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) China's glyphosate and PMIDA manufacturers are still facing the pressure of compliance with the...

2014-02-20 12:22:59

DUBLIN, Feb. 20, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/w3f3qp/glyphosate_china ) has announced the addition of the "Glyphosate China Monthly Report 1401" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The ex-works price of glyphosate technical kept decreasing since September 2013 after reaching the highest, and it witnessed the lowest in December 2013, with RMB30,000/t. However, compared with December...

High Dose Antidepressant Offers Some Hope For Alzheimer's Patients
2014-02-19 12:58:56

Brett Smith for redOrbit.com - Your Universe Online Agitation is a common symptom in patients with Alzheimer's disease and is associated with severe adverse consequences for both patients and caregivers. According to a new study published in JAMA, a high dose of the antidepressant citalopram considerably reduced agitation in patients with Alzheimer’s. However, the drug administered at this dose was also associated with mild adverse cognitive and cardiac effects – a sign that this...

2014-02-18 04:20:49

ALBANY, New York, February 18, 2014 /PRNewswire/ -- MarketResearchReports.Biz includes new market research report " Cystic Fibrosis Therapeutics In Major Developed Markets To 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatment And Market Growth" to its large collection of research reports....

2014-02-13 23:02:55

Comprehensive analysis and forecast on the melamine market at different geographical levels can be found in the in-demand research study “Melamine: 2014 World Market Outlook and Forecast up to 2018” prepared by Merchant Research & Consulting and recently published by Market Publishers Ltd. According to the report, in 2018, the global melamine supply is poised to surpass the 2 million tonnes mark. London, UK (PRWEB) February 13, 2014 During 2009-2010, unfavourable economic...

2014-01-29 16:28:52

MALVERN, Pa., Jan. 29, 2014 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today confirmed that the United States District Court for the District of Delaware ruled that United States Patent No. 5,464,864, Endo's patent covering frovatriptan, the active ingredient in FROVA(® )(frovatriptan succinate) tablets, is valid and infringed. The Court's decision prevents Mylan from marketing its generic version of FROVA(®) in the U.S. before Endo's patent expires November 8, 2015,...

2014-01-14 04:21:01

SEATTLE, Jan. 14, 2014 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced a corporate update for 2014 in addition to an overview of recent progress for its drug portfolio. "We ended 2013 and have entered 2014 with a series of successes, including a global strategic partnership for pacritinib, positive reimbursement rulings in England/Wales and Germany for PIXUVRI, the reacquisition of rights to PIXUVRI and Opaxio in order to allow us to more efficiently move...

2014-01-13 12:28:09

To combat the advance of painkiller abuse around the world, the leading supplement for withdrawal is going global AUSTIN, Texas, Jan. 13, 2014 /PRNewswire/ -- In an effort to combat global prescription drug abuse, Withdrawal Ease -- the leading nutritional supplement system designed to help ease the physical and emotional discomfort of withdrawal -- has announced its launch into Canada and Australia. Countries in the U.K., Europe and South America are expected to follow later in...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related